Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis
{{output}}
Background: Tumor neoantigen peptide-based vaccines, systemic immunotherapies that enhance antitumor immunity by activating and expanding antigen-specific T cells, have achieved remarkable results in the treatment of a variety of... ...
